Dr. Noah A. Kolb, MD

Dr. Kolb practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Kolb's NPI, 1427217264, was assigned on June 6, 2008. Dr. Kolb graduated from University of Massachusetts Medical School in 2008. Dr. Kolb holds Vermont license 042.0013373.

Dr. Kolb's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Kolb's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Kolb is also affiliated with Champlain Valley Physicians Hospital. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Kolb to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolb practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kolb's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kolb is licensed in Vermont.

CMS data shows 384 Medicare services from Dr. Kolb across 11 procedure codes in 2024, for 199 Medicare patients. Medicare paid $20,028 for them.

CMS counts 199 Medicare patients who saw Dr. Kolb in 2024. The largest group is 65 to 74, with 84 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kolb's median patient age at 69, with 52% women.

In 2024, Dr. Kolb wrote 539 Medicare Part D claims for 85 patients. 90% of them were for generic drugs. CMS names the drug for 446 of them, across 13 drugs with 11 or more claims each, at $435,737 in total drug cost. In 2023, CMS named 426 claims across 13 drugs.

Dr. Kolb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kolb as offering telehealth.

Dmand AI links 24 papers to Dr. Kolb, published from 2015 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Peripheral Nervous System Diseases, Antineoplastic Agents and Neurotoxicity Syndromes. Dr. Kolb has published most often in Muscle Nerve. Dr. Kolb's most frequent co-authors are Michael K. Hehir, MD, Kim Lynnette Dittus, MD, PhD and James K. Richardson, MD.

Dmand AI links Dr. Kolb to 1 clinical trial. Conditions studied include Miller Fisher Syndrome and Guillain-Barre Syndrome.

CMS Open Payments shows 31 general payments to Dr. Kolb from 5 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 76% of the total. Argenx US, Inc. paid the most, $16,178.

Dr. Kolb graduated from University of Massachusetts Medical School in 2008.